Summaries & Associations of Study Results
TR-049 Acronycine
Target Organs and Levels of Evidence
NTP Technical Report Number 049
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| ACRONYCINE 7008-42-6 |
03/07/78 | ANTICANCER DRUG | Intraperitoneal Injection R: 0,3.75,7.5,15, M: 0,2,6,12.5,25 MG/KG/35 PER GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: POSITIVE | BONE (OSTEOSARCOMA) | |||
| MESOTHELIUM (ABDOMINAL CAVITY/TUNICA VAGINALIS): MESOTHELIOMA; SARCOMA | ||||
| FR: POSITIVE | MAMMARY GLAND (ADENOCARCINOMA) | |||
| MESOTHELIUM (ABDOMINAL CAVITY/TUNICA VAGINALIS): MESOTHELIOMA; SARCOMA | ||||
| MM: INADEQUATE STUDY | ||||
| FM: INADEQUATE STUDY | ||||
Web page last updated on February 10, 2006
